_MEMBER_MyList,_LogP_MyList,GO,Description,_PATTERN_,_RANK_,GiniIndex
1,-4.7,GO:0010035,response to inorganic substance,M1,1,0
1,-4.4,GO:0043154,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,M1,1,0
1,-2.7,GO:0045766,positive regulation of angiogenesis,M1,1,0
1,-2,R-HSA-176187,Activation of ATR in response to replication stress,M1,1,0
1,-2.4,GO:0016101,diterpenoid metabolic process,M1,1,0
1,-2,GO:0046365,monosaccharide catabolic process,M1,1,0
1,-5.3,M3008,NABA ECM GLYCOPROTEINS,M1,1,0
1,-6.8,GO:0001655,urogenital system development,M1,1,0
1,-3.2,hsa01212,Fatty acid metabolism,M1,1,0
1,-2,GO:0072028,nephron morphogenesis,M1,1,0
1,-2.5,GO:0051897,positive regulation of protein kinase B signaling,M1,1,0
1,-2.4,GO:0071549,cellular response to dexamethasone stimulus,M1,1,0
1,-2.7,GO:0003081,regulation of systemic arterial blood pressure by renin-angiotensin,M1,1,0
1,-3.1,GO:0019693,ribose phosphate metabolic process,M1,1,0
1,-2.5,GO:0035336,long-chain fatty-acyl-CoA metabolic process,M1,1,0
1,-2.4,GO:0071320,cellular response to cAMP,M1,1,0
1,-2.7,GO:0009126,purine nucleoside monophosphate metabolic process,M1,1,0
1,-2,GO:0045600,positive regulation of fat cell differentiation,M1,1,0
1,-3,GO:0038083,peptidyl-tyrosine autophosphorylation,M1,1,0
1,-2.2,GO:0033157,regulation of intracellular protein transport,M1,1,0
1,-3.9,GO:0000278,mitotic cell cycle,M1,1,0
1,-3.5,GO:0061061,muscle structure development,M1,1,0
1,-2.1,GO:0035335,peptidyl-tyrosine dephosphorylation,M1,1,0
1,-3.5,GO:0001885,endothelial cell development,M1,1,0
1,-3.2,GO:0060249,anatomical structure homeostasis,M1,1,0
1,-2.4,M33,PID GLYPICAN 1PATHWAY,M1,1,0
1,-2,GO:0140448,signaling receptor ligand precursor processing,M1,1,0
1,-2.5,GO:0060560,developmental growth involved in morphogenesis,M1,1,0
1,-2.2,GO:0002040,sprouting angiogenesis,M1,1,0
1,-3.7,GO:0001558,regulation of cell growth,M1,1,0
1,-8.6,GO:0009792,embryo development ending in birth or egg hatching,M1,1,0
1,-2.2,R-HSA-389661,Glyoxylate metabolism and glycine degradation,M1,1,0
1,-5,GO:0097237,cellular response to toxic substance,M1,1,0
1,-7.2,GO:0001568,blood vessel development,M1,1,0
1,-4,GO:0002138,retinoic acid biosynthetic process,M1,1,0
1,-2.1,WP2877,Vitamin D receptor pathway,M1,1,0
1,-3.2,GO:0042330,taxis,M1,1,0
1,-2.4,GO:0001892,embryonic placenta development,M1,1,0
1,-3.5,GO:0055086,nucleobase-containing small molecule metabolic process,M1,1,0
1,-3.8,WP272,Blood clotting cascade,M1,1,0
1,-4.2,GO:0030324,lung development,M1,1,0
1,-2.6,GO:0003151,outflow tract morphogenesis,M1,1,0
1,-2.8,GO:0140694,non-membrane-bounded organelle assembly,M1,1,0
1,-3.4,GO:0071241,cellular response to inorganic substance,M1,1,0
1,-7,GO:0010951,negative regulation of endopeptidase activity,M1,1,0
1,-4,GO:0009069,serine family amino acid metabolic process,M1,1,0
1,-4,GO:0070294,renal sodium ion absorption,M1,1,0
1,-2.5,GO:0036293,response to decreased oxygen levels,M1,1,0
1,-2.9,GO:0048754,branching morphogenesis of an epithelial tube,M1,1,0
1,-3.3,GO:0006935,chemotaxis,M1,1,0
1,-3.2,GO:0010232,vascular transport,M1,1,0
1,-2,GO:0007589,body fluid secretion,M1,1,0
1,-2.9,GO:0010092,specification of animal organ identity,M1,1,0
1,-3.3,GO:0030029,actin filament-based process,M1,1,0
1,-2.9,GO:0070293,renal absorption,M1,1,0
1,-2,GO:0035850,epithelial cell differentiation involved in kidney development,M1,1,0
1,-2.9,R-HSA-2129379,Molecules associated with elastic fibres,M1,1,0
1,-3.2,GO:0015695,organic cation transport,M1,1,0
1,-2.8,GO:1905517,macrophage migration,M1,1,0
1,-7.9,R-HSA-556833,Metabolism of lipids,M1,1,0
1,-2.1,GO:0006301,postreplication repair,M1,1,0
1,-2.5,GO:0045860,positive regulation of protein kinase activity,M1,1,0
1,-2.1,GO:0051930,regulation of sensory perception of pain,M1,1,0
1,-2.6,GO:0030155,regulation of cell adhesion,M1,1,0
1,-3.5,GO:1901890,positive regulation of cell junction assembly,M1,1,0
1,-2.9,GO:0043254,regulation of protein-containing complex assembly,M1,1,0
1,-3,R-HSA-8956319,Nucleotide catabolism,M1,1,0
1,-5.9,GO:0071214,cellular response to abiotic stimulus,M1,1,0
1,-2.2,GO:1903046,meiotic cell cycle process,M1,1,0
1,-3.1,GO:0060606,tube closure,M1,1,0
1,-4,GO:1903035,negative regulation of response to wounding,M1,1,0
1,-2.9,GO:0010634,positive regulation of epithelial cell migration,M1,1,0
1,-3.4,GO:0001890,placenta development,M1,1,0
1,-3.7,GO:0040007,growth,M1,1,0
1,-6,GO:0055067,monovalent inorganic cation homeostasis,M1,1,0
1,-4.1,GO:2000117,negative regulation of cysteine-type endopeptidase activity,M1,1,0
1,-2.7,GO:0071383,cellular response to steroid hormone stimulus,M1,1,0
1,-5.2,GO:0030001,metal ion transport,M1,1,0
1,-3.1,GO:0031349,positive regulation of defense response,M1,1,0
1,-2.3,GO:0015701,bicarbonate transport,M1,1,0
1,-3.5,GO:0046903,secretion,M1,1,0
1,-2.9,GO:0046040,IMP metabolic process,M1,1,0
1,-2.8,GO:0031333,negative regulation of protein-containing complex assembly,M1,1,0
1,-2.4,GO:0008202,steroid metabolic process,M1,1,0
1,-3.7,R-HSA-3906995,Diseases associated with O-glycosylation of proteins,M1,1,0
1,-2.3,GO:0031214,biomineral tissue development,M1,1,0
1,-4.6,GO:0050819,negative regulation of coagulation,M1,1,0
1,-3.4,GO:0044089,positive regulation of cellular component biogenesis,M1,1,0
1,-3,GO:0009119,ribonucleoside metabolic process,M1,1,0
1,-2.6,GO:0031099,regeneration,M1,1,0
1,-2.2,GO:0098609,cell-cell adhesion,M1,1,0
1,-2.4,WP2406,Cardiac progenitor differentiation,M1,1,0
1,-3.7,GO:0032147,activation of protein kinase activity,M1,1,0
1,-3,R-HSA-1222556,ROS and RNS production in phagocytes,M1,1,0
1,-7.2,GO:0061458,reproductive system development,M1,1,0
1,-2.1,GO:0031667,response to nutrient levels,M1,1,0
1,-2.5,GO:0033260,nuclear DNA replication,M1,1,0
1,-2.6,GO:1900744,regulation of p38MAPK cascade,M1,1,0
1,-4.1,hsa04960,Aldosterone-regulated sodium reabsorption,M1,1,0
1,-3.2,R-HSA-68962,Activation of the pre-replicative complex,M1,1,0
1,-9.2,R-HSA-1483206,Glycerophospholipid biosynthesis,M1,1,0
1,-3.2,GO:0061572,actin filament bundle organization,M1,1,0
1,-2.4,hsa04512,ECM-receptor interaction,M1,1,0
1,-2.3,M100,PID SHP2 PATHWAY,M1,1,0
1,-3.1,GO:0007059,chromosome segregation,M1,1,0
1,-3.5,GO:2000147,positive regulation of cell motility,M1,1,0
1,-2.2,GO:0043473,pigmentation,M1,1,0
1,-3.2,GO:0001934,positive regulation of protein phosphorylation,M1,1,0
1,-2.5,GO:0060993,kidney morphogenesis,M1,1,0
1,-2.1,GO:0031589,cell-substrate adhesion,M1,1,0
1,-3.9,GO:0006873,cellular ion homeostasis,M1,1,0
1,-2.9,R-HSA-194315,Signaling by Rho GTPases,M1,1,0
1,-2.2,GO:0042246,tissue regeneration,M1,1,0
1,-6.8,GO:0010466,negative regulation of peptidase activity,M1,1,0
1,-3,WP3624,Lung fibrosis,M1,1,0
1,-3.1,GO:0098659,inorganic cation import across plasma membrane,M1,1,0
1,-2.5,GO:0009162,deoxyribonucleoside monophosphate metabolic process,M1,1,0
1,-2.2,GO:0043409,negative regulation of MAPK cascade,M1,1,0
1,-2.6,WP2848,Pluripotent stem cell differentiation pathway,M1,1,0
1,-3.3,GO:0007167,enzyme linked receptor protein signaling pathway,M1,1,0
1,-2.9,WP5033,Genes associated with the development of rheumatoid arthritis,M1,1,0
1,-2.3,GO:0007596,blood coagulation,M1,1,0
1,-3.9,WP15,Selenium micronutrient network,M1,1,0
1,-2.5,GO:0070848,response to growth factor,M1,1,0
1,-3.1,hsa04919,Thyroid hormone signaling pathway,M1,1,0
1,-2.2,GO:0036230,granulocyte activation,M1,1,0
1,-5.7,GO:0006814,sodium ion transport,M1,1,0
1,-2.5,GO:0002573,myeloid leukocyte differentiation,M1,1,0
1,-4.3,GO:0071407,cellular response to organic cyclic compound,M1,1,0
1,-2.4,GO:0009410,response to xenobiotic stimulus,M1,1,0
1,-3.2,GO:0055065,metal ion homeostasis,M1,1,0
1,-4.4,GO:0098754,detoxification,M1,1,0
1,-4.4,R-HSA-76005,Response to elevated platelet cytosolic Ca2+,M1,1,0
1,-3.8,GO:0030832,regulation of actin filament length,M1,1,0
1,-2.2,M242,PID AURORA A PATHWAY,M1,1,0
1,-2.4,GO:0035383,thioester metabolic process,M1,1,0
1,-3.2,GO:0071305,cellular response to vitamin D,M1,1,0
1,-2.9,GO:0099518,vesicle cytoskeletal trafficking,M1,1,0
1,-2.6,GO:1901654,response to ketone,M1,1,0
1,-2.7,hsa01524,Platinum drug resistance,M1,1,0
1,-2.5,GO:0010817,regulation of hormone levels,M1,1,0
1,-2.1,hsa05165,Human papillomavirus infection,M1,1,0
1,-2.1,GO:0001990,regulation of systemic arterial blood pressure by hormone,M1,1,0
1,-2.2,GO:0090130,tissue migration,M1,1,0
1,-3.2,GO:0072337,modified amino acid transport,M1,1,0
1,-3.8,GO:0046470,phosphatidylcholine metabolic process,M1,1,0
1,-2.7,GO:0006753,nucleoside phosphate metabolic process,M1,1,0
1,-2.8,GO:0060322,head development,M1,1,0
1,-3.9,GO:0090407,organophosphate biosynthetic process,M1,1,0
1,-4.8,GO:0048729,tissue morphogenesis,M1,1,0
1,-2.4,GO:0046337,phosphatidylethanolamine metabolic process,M1,1,0
1,-2.4,GO:0043281,regulation of cysteine-type endopeptidase activity involved in apoptotic process,M1,1,0
1,-3.5,GO:0045927,positive regulation of growth,M1,1,0
1,-2.4,GO:0046889,positive regulation of lipid biosynthetic process,M1,1,0
1,-2.2,R-HSA-9013423,RAC3 GTPase cycle,M1,1,0
1,-3.8,GO:0022407,regulation of cell-cell adhesion,M1,1,0
1,-2.3,WP2361,Gastric cancer network 1,M1,1,0
1,-2.3,GO:0071363,cellular response to growth factor stimulus,M1,1,0
1,-2.9,GO:0009125,nucleoside monophosphate catabolic process,M1,1,0
1,-2.7,GO:0018108,peptidyl-tyrosine phosphorylation,M1,1,0
1,-7.7,GO:0046486,glycerolipid metabolic process,M1,1,0
1,-2.2,hsa04978,Mineral absorption,M1,1,0
1,-2.2,R-HSA-6798695,Neutrophil degranulation,M1,1,0
1,-4.6,GO:0007015,actin filament organization,M1,1,0
1,-2.7,GO:0009070,serine family amino acid biosynthetic process,M1,1,0
1,-2.2,GO:0071384,cellular response to corticosteroid stimulus,M1,1,0
1,-2.6,GO:0090335,regulation of brown fat cell differentiation,M1,1,0
1,-5.8,GO:0009611,response to wounding,M1,1,0
1,-3.9,GO:0043062,extracellular structure organization,M1,1,0
1,-3,GO:0048645,animal organ formation,M1,1,0
1,-2.8,R-HSA-9716542,"Signaling by Rho GTPases, Miro GTPases and RHOBTB3",M1,1,0
1,-3.3,GO:0098656,anion transmembrane transport,M1,1,0
1,-3.5,WP3888,VEGFA-VEGFR2 signaling pathway,M1,1,0
1,-3,GO:0031175,neuron projection development,M1,1,0
1,-2.9,WP5087,Malignant pleural mesothelioma,M1,1,0
1,-2.6,GO:0006260,DNA replication,M1,1,0
1,-7.8,GO:0044283,small molecule biosynthetic process,M1,1,0
1,-3.1,GO:0032102,negative regulation of response to external stimulus,M1,1,0
1,-2.9,GO:0062197,cellular response to chemical stress,M1,1,0
1,-6.9,GO:0006644,phospholipid metabolic process,M1,1,0
1,-2.1,GO:0090090,negative regulation of canonical Wnt signaling pathway,M1,1,0
1,-3.8,M174,PID UPA UPAR PATHWAY,M1,1,0
1,-3.4,GO:0032103,positive regulation of response to external stimulus,M1,1,0
1,-2.1,GO:0072088,nephron epithelium morphogenesis,M1,1,0
1,-2.9,GO:0035337,fatty-acyl-CoA metabolic process,M1,1,0
1,-3.5,GO:0030258,lipid modification,M1,1,0
1,-5.3,GO:0055080,cation homeostasis,M1,1,0
1,-2.8,WP466,DNA replication,M1,1,0
1,-2.5,GO:0046033,AMP metabolic process,M1,1,0
1,-2.2,GO:2000241,regulation of reproductive process,M1,1,0
1,-4.2,R-HSA-74259,Purine catabolism,M1,1,0
1,-2.8,GO:0009064,glutamine family amino acid metabolic process,M1,1,0
1,-2.8,GO:0016054,organic acid catabolic process,M1,1,0
1,-2.1,GO:0035150,regulation of tube size,M1,1,0
1,-2,GO:0007420,brain development,M1,1,0
1,-2.9,GO:0198738,cell-cell signaling by wnt,M1,1,0
1,-2.7,GO:0120161,regulation of cold-induced thermogenesis,M1,1,0
1,-2.3,GO:0002090,regulation of receptor internalization,M1,1,0
1,-3.9,GO:0048545,response to steroid hormone,M1,1,0
1,-3.1,GO:0090336,positive regulation of brown fat cell differentiation,M1,1,0
1,-3.9,GO:1901989,positive regulation of cell cycle phase transition,M1,1,0
1,-7.2,GO:0048608,reproductive structure development,M1,1,0
1,-2.4,GO:0042119,neutrophil activation,M1,1,0
1,-2.5,GO:0030282,bone mineralization,M1,1,0
1,-2.6,GO:0018212,peptidyl-tyrosine modification,M1,1,0
1,-3.2,GO:0045684,positive regulation of epidermis development,M1,1,0
1,-2.7,GO:0019722,calcium-mediated signaling,M1,1,0
1,-2.1,GO:0019751,polyol metabolic process,M1,1,0
1,-2.5,GO:0072523,purine-containing compound catabolic process,M1,1,0
1,-4.1,WP5053,Development of ureteric collection system,M1,1,0
1,-2.8,WP516,Hypertrophy model,M1,1,0
1,-2.3,M77,PID WNT SIGNALING PATHWAY,M1,1,0
1,-2.1,GO:0019229,regulation of vasoconstriction,M1,1,0
1,-2.7,WP4136,Fibrin complement receptor 3 signaling pathway,M1,1,0
1,-2.3,GO:0001775,cell activation,M1,1,0
1,-2.7,R-HSA-1566948,Elastic fibre formation,M1,1,0
1,-2.2,GO:0061037,negative regulation of cartilage development,M1,1,0
1,-3.1,GO:0051494,negative regulation of cytoskeleton organization,M1,1,0
1,-2.8,GO:0006641,triglyceride metabolic process,M1,1,0
1,-2.7,GO:0006195,purine nucleotide catabolic process,M1,1,0
1,-3.7,GO:0030335,positive regulation of cell migration,M1,1,0
1,-2.9,GO:1905039,carboxylic acid transmembrane transport,M1,1,0
1,-3.1,GO:0072176,nephric duct development,M1,1,0
1,-7,GO:0072330,monocarboxylic acid biosynthetic process,M1,1,0
1,-2.7,GO:0090263,positive regulation of canonical Wnt signaling pathway,M1,1,0
1,-3.4,GO:0001676,long-chain fatty acid metabolic process,M1,1,0
1,-3.4,R-HSA-425393,Transport of inorganic cations/anions and amino acids/oligopeptides,M1,1,0
1,-2,GO:0043542,endothelial cell migration,M1,1,0
1,-2.6,GO:0045664,regulation of neuron differentiation,M1,1,0
1,-3.5,GO:0033280,response to vitamin D,M1,1,0
1,-2.1,GO:0030148,sphingolipid biosynthetic process,M1,1,0
1,-3.4,GO:0016331,morphogenesis of embryonic epithelium,M1,1,0
1,-3.2,GO:0031960,response to corticosteroid,M1,1,0
1,-4.3,GO:0030004,cellular monovalent inorganic cation homeostasis,M1,1,0
1,-3.9,GO:0045229,external encapsulating structure organization,M1,1,0
1,-2.7,GO:0072112,glomerular visceral epithelial cell differentiation,M1,1,0
1,-2.3,GO:0110148,biomineralization,M1,1,0
1,-2.7,GO:0001667,ameboidal-type cell migration,M1,1,0
1,-2.7,GO:0007588,excretion,M1,1,0
1,-7.3,M5885,NABA MATRISOME ASSOCIATED,M1,1,0
1,-2.5,GO:1903829,positive regulation of protein localization,M1,1,0
1,-2.5,GO:0044786,cell cycle DNA replication,M1,1,0
1,-5.1,GO:0044282,small molecule catabolic process,M1,1,0
1,-2.1,GO:0097746,blood vessel diameter maintenance,M1,1,0
1,-4.2,GO:0030177,positive regulation of Wnt signaling pathway,M1,1,0
1,-3.1,GO:0032386,regulation of intracellular transport,M1,1,0
1,-2,GO:1902305,regulation of sodium ion transmembrane transport,M1,1,0
1,-2.5,WP1539,Angiogenesis,M1,1,0
1,-2.7,R-HSA-8957275,Post-translational protein phosphorylation,M1,1,0
1,-2.1,GO:0034110,regulation of homotypic cell-cell adhesion,M1,1,0
1,-3,GO:0010632,regulation of epithelial cell migration,M1,1,0
1,-3.9,GO:0030036,actin cytoskeleton organization,M1,1,0
1,-7.8,hsa05418,Fluid shear stress and atherosclerosis,M1,1,0
1,-4,GO:0021915,neural tube development,M1,1,0
1,-2.4,GO:0015909,long-chain fatty acid transport,M1,1,0
1,-2,R-HSA-190861,Gap junction assembly,M1,1,0
1,-3,GO:0072073,kidney epithelium development,M1,1,0
1,-3.4,GO:0045859,regulation of protein kinase activity,M1,1,0
1,-2.4,GO:0060441,epithelial tube branching involved in lung morphogenesis,M1,1,0
1,-2.5,GO:0045662,negative regulation of myoblast differentiation,M1,1,0
1,-3.1,GO:0051129,negative regulation of cellular component organization,M1,1,0
1,-3.1,GO:0048880,sensory system development,M1,1,0
1,-2.3,GO:1901606,alpha-amino acid catabolic process,M1,1,0
1,-6.3,GO:0001525,angiogenesis,M1,1,0
1,-2.7,M103,PID S1P S1P1 PATHWAY,M1,1,0
1,-2.4,GO:0006954,inflammatory response,M1,1,0
1,-2.4,GO:0001838,embryonic epithelial tube formation,M1,1,0
1,-2.4,GO:0071695,anatomical structure maturation,M1,1,0
1,-2.7,GO:0035148,tube formation,M1,1,0
1,-3.9,GO:0032535,regulation of cellular component size,M1,1,0
1,-3.2,GO:0150063,visual system development,M1,1,0
1,-5.3,GO:0009725,response to hormone,M1,1,0
1,-3,GO:0048771,tissue remodeling,M1,1,0
1,-2.6,GO:0031032,actomyosin structure organization,M1,1,0
1,-3,GO:0072521,purine-containing compound metabolic process,M1,1,0
1,-4.3,M44,PID HIF2PATHWAY,M1,1,0
1,-2.5,GO:0008283,cell population proliferation,M1,1,0
1,-5.9,GO:0104004,cellular response to environmental stimulus,M1,1,0
1,-2.9,GO:0014074,response to purine-containing compound,M1,1,0
1,-2.5,GO:0051301,cell division,M1,1,0
1,-3.9,GO:0006883,cellular sodium ion homeostasis,M1,1,0
1,-6.2,GO:0050801,ion homeostasis,M1,1,0
1,-2.5,R-HSA-1187000,Fertilization,M1,1,0
1,-2.7,GO:0061318,renal filtration cell differentiation,M1,1,0
1,-2.3,GO:2000649,regulation of sodium ion transmembrane transporter activity,M1,1,0
1,-3.2,GO:0046942,carboxylic acid transport,M1,1,0
1,-2.9,R-HSA-9012999,RHO GTPase cycle,M1,1,0
1,-3.1,GO:0032271,regulation of protein polymerization,M1,1,0
1,-8.4,GO:0016053,organic acid biosynthetic process,M1,1,0
1,-3.3,GO:0043549,regulation of kinase activity,M1,1,0
1,-3.4,GO:0050727,regulation of inflammatory response,M1,1,0
1,-2.3,hsa00650,Butanoate metabolism,M1,1,0
1,-2.2,GO:0006638,neutral lipid metabolic process,M1,1,0
1,-2.3,GO:0051952,regulation of amine transport,M1,1,0
1,-2.3,GO:0010453,regulation of cell fate commitment,M1,1,0
1,-2.7,GO:0033674,positive regulation of kinase activity,M1,1,0
1,-3.3,GO:0048246,macrophage chemotaxis,M1,1,0
1,-6.2,GO:0050878,regulation of body fluid levels,M1,1,0
1,-4.8,GO:0098869,cellular oxidant detoxification,M1,1,0
1,-2.3,GO:0006081,cellular aldehyde metabolic process,M1,1,0
1,-2.6,GO:0033273,response to vitamin,M1,1,0
1,-4.3,GO:0043603,cellular amide metabolic process,M1,1,0
1,-2.1,GO:0007276,gamete generation,M1,1,0
1,-4.5,GO:0006564,L-serine biosynthetic process,M1,1,0
1,-2.7,GO:0071636,positive regulation of transforming growth factor beta production,M1,1,0
1,-2.8,GO:1903825,organic acid transmembrane transport,M1,1,0
1,-2.2,R-HSA-71291,Metabolism of amino acids and derivatives,M1,1,0
1,-3.3,GO:0051017,actin filament bundle assembly,M1,1,0
1,-2.8,hsa05204,Chemical carcinogenesis - DNA adducts,M1,1,0
1,-2.8,GO:0009167,purine ribonucleoside monophosphate metabolic process,M1,1,0
1,-2.5,GO:0042304,regulation of fatty acid biosynthetic process,M1,1,0
1,-3.1,GO:0001843,neural tube closure,M1,1,0
1,-2.9,GO:0120162,positive regulation of cold-induced thermogenesis,M1,1,0
1,-3.7,M137,PID VEGF VEGFR PATHWAY,M1,1,0
1,-4.8,GO:0006790,sulfur compound metabolic process,M1,1,0
1,-4.1,R-HSA-425366,"Transport of bile salts and organic acids, metal ions and amine compounds",M1,1,0
1,-2.7,GO:0008217,regulation of blood pressure,M1,1,0
1,-2.9,GO:0022604,regulation of cell morphogenesis,M1,1,0
1,-2.7,R-HSA-9013106,RHOC GTPase cycle,M1,1,0
1,-2.2,WP129,Matrix metalloproteinases,M1,1,0
1,-3.2,GO:0055075,potassium ion homeostasis,M1,1,0
1,-2.1,GO:0061842,microtubule organizing center localization,M1,1,0
1,-2.1,GO:0016486,peptide hormone processing,M1,1,0
1,-2.4,GO:0071467,cellular response to pH,M1,1,0
1,-2.6,GO:0045834,positive regulation of lipid metabolic process,M1,1,0
1,-2.3,GO:1901655,cellular response to ketone,M1,1,0
1,-2.8,GO:0008406,gonad development,M1,1,0
1,-5.1,GO:0015711,organic anion transport,M1,1,0
1,-5.6,GO:0090066,regulation of anatomical structure size,M1,1,0
1,-4.2,GO:0000038,very long-chain fatty acid metabolic process,M1,1,0
1,-4.6,GO:0050818,regulation of coagulation,M1,1,0
1,-4.4,GO:0003013,circulatory system process,M1,1,0
1,-4.6,GO:0040008,regulation of growth,M1,1,0
1,-4,R-HSA-195399,VEGF binds to VEGFR leading to receptor dimerization,M1,1,0
1,-2.5,GO:0060348,bone development,M1,1,0
1,-2.2,GO:0009161,ribonucleoside monophosphate metabolic process,M1,1,0
1,-2.2,GO:0042596,fear response,M1,1,0
1,-3.1,R-HSA-983189,Kinesins,M1,1,0
1,-2.8,GO:0051384,response to glucocorticoid,M1,1,0
1,-2,GO:0000725,recombinational repair,M1,1,0
1,-2.9,GO:1901607,alpha-amino acid biosynthetic process,M1,1,0
1,-3.3,R-HSA-1482839,Acyl chain remodelling of PE,M1,1,0
1,-2.4,GO:0048469,cell maturation,M1,1,0
1,-5.5,GO:0042060,wound healing,M1,1,0
1,-3.1,GO:0035633,maintenance of blood-brain barrier,M1,1,0
1,-3.7,GO:1902600,proton transmembrane transport,M1,1,0
1,-2.2,hsa05208,Chemical carcinogenesis - reactive oxygen species,M1,1,0
1,-3.1,GO:0099587,inorganic ion import across plasma membrane,M1,1,0
1,-4.9,GO:0043086,negative regulation of catalytic activity,M1,1,0
1,-5.4,GO:0051346,negative regulation of hydrolase activity,M1,1,0
1,-2.3,GO:0010595,positive regulation of endothelial cell migration,M1,1,0
1,-2.5,GO:0045165,cell fate commitment,M1,1,0
1,-2.6,GO:0048285,organelle fission,M1,1,0
1,-2.2,GO:1900745,positive regulation of p38MAPK cascade,M1,1,0
1,-2.1,GO:0031670,cellular response to nutrient,M1,1,0
1,-3.5,GO:0043408,regulation of MAPK cascade,M1,1,0
1,-2.3,M169,PID INTEGRIN2 PATHWAY,M1,1,0
1,-5.2,GO:0060541,respiratory system development,M1,1,0
1,-2.1,GO:0048008,platelet-derived growth factor receptor signaling pathway,M1,1,0
1,-3.6,GO:0051604,protein maturation,M1,1,0
1,-3.8,GO:0043010,camera-type eye development,M1,1,0
1,-2.2,M165,PID SYNDECAN 4 PATHWAY,M1,1,0
1,-3.9,GO:0110053,regulation of actin filament organization,M1,1,0
1,-2.6,GO:0003401,axis elongation,M1,1,0
1,-2.4,GO:0048593,camera-type eye morphogenesis,M1,1,0
1,-2.4,GO:0071277,cellular response to calcium ion,M1,1,0
1,-3.3,GO:0001991,regulation of systemic arterial blood pressure by circulatory renin-angiotensin,M1,1,0
1,-2.8,GO:0071548,response to dexamethasone,M1,1,0
1,-2.3,GO:0006270,DNA replication initiation,M1,1,0
1,-2.7,GO:2000116,regulation of cysteine-type endopeptidase activity,M1,1,0
1,-2.4,GO:0060326,cell chemotaxis,M1,1,0
1,-2.3,GO:0007160,cell-matrix adhesion,M1,1,0
1,-4.9,M53,PID INTEGRIN3 PATHWAY,M1,1,0
1,-2.9,GO:0030866,cortical actin cytoskeleton organization,M1,1,0
1,-2.9,WP2806,Complement system,M1,1,0
1,-2,R-HSA-156590,Glutathione conjugation,M1,1,0
1,-2.7,WP2884,NRF2 pathway,M1,1,0
1,-2.5,GO:0015833,peptide transport,M1,1,0
1,-2,GO:0002066,columnar/cuboidal epithelial cell development,M1,1,0
1,-2.1,GO:0045787,positive regulation of cell cycle,M1,1,0
1,-4,WP4018,Clear cell renal cell carcinoma pathways,M1,1,0
1,-2.2,GO:0042044,fluid transport,M1,1,0
1,-3.4,R-HSA-76002,"Platelet activation, signaling and aggregation",M1,1,0
1,-3.3,GO:0099550,"trans-synaptic signaling, modulating synaptic transmission",M1,1,0
1,-3.1,WP408,Oxidative stress response,M1,1,0
1,-2.3,GO:0010464,regulation of mesenchymal cell proliferation,M1,1,0
1,-4,GO:0030198,extracellular matrix organization,M1,1,0
1,-2.1,hsa05217,Basal cell carcinoma,M1,1,0
1,-6.1,hsa00062,Fatty acid elongation,M1,1,0
1,-2.4,GO:2000177,regulation of neural precursor cell proliferation,M1,1,0
1,-9,GO:0043009,chordate embryonic development,M1,1,0
1,-4.7,GO:0030111,regulation of Wnt signaling pathway,M1,1,0
1,-6.7,R-HSA-1474244,Extracellular matrix organization,M1,1,0
1,-3.3,GO:0007169,transmembrane receptor protein tyrosine kinase signaling pathway,M1,1,0
1,-3.2,GO:0042359,vitamin D metabolic process,M1,1,0
1,-3.8,GO:0034308,primary alcohol metabolic process,M1,1,0
1,-4.6,GO:0097435,supramolecular fiber organization,M1,1,0
1,-3.4,GO:0040017,positive regulation of locomotion,M1,1,0
1,-2.2,GO:0000165,MAPK cascade,M1,1,0
1,-2,GO:0032231,regulation of actin filament bundle assembly,M1,1,0
1,-2.1,WP702,Metapathway biotransformation Phase I and II,M1,1,0
1,-5.7,GO:0042730,fibrinolysis,M1,1,0
1,-2.7,GO:2000047,regulation of cell-cell adhesion mediated by cadherin,M1,1,0
1,-2.2,GO:0006310,DNA recombination,M1,1,0
1,-2.8,GO:0055123,digestive system development,M1,1,0
1,-2.5,hsa04979,Cholesterol metabolism,M1,1,0
1,-2.7,hsa01230,Biosynthesis of amino acids,M1,1,0
1,-8.4,GO:0046394,carboxylic acid biosynthetic process,M1,1,0
1,-2.7,R-HSA-2672351,Stimuli-sensing channels,M1,1,0
1,-2.2,GO:0042573,retinoic acid metabolic process,M1,1,0
1,-5.2,GO:0055078,sodium ion homeostasis,M1,1,0
1,-5.9,WP98,Prostaglandin synthesis and regulation,M1,1,0
1,-2.8,GO:0000280,nuclear division,M1,1,0
1,-2.9,GO:1903047,mitotic cell cycle process,M1,1,0
1,-2.6,R-HSA-5173105,O-linked glycosylation,M1,1,0
1,-2.5,GO:0032388,positive regulation of intracellular transport,M1,1,0
1,-2.4,hsa01040,Biosynthesis of unsaturated fatty acids,M1,1,0
1,-3.1,GO:1901657,glycosyl compound metabolic process,M1,1,0
1,-6.5,GO:0045861,negative regulation of proteolysis,M1,1,0
1,-3.9,GO:0071248,cellular response to metal ion,M1,1,0
1,-2.8,GO:0033559,unsaturated fatty acid metabolic process,M1,1,0
1,-3.5,GO:0045606,positive regulation of epidermal cell differentiation,M1,1,0
1,-6.8,GO:0009636,response to toxic substance,M1,1,0
1,-4.6,hsa00564,Glycerophospholipid metabolism,M1,1,0
1,-2.5,WP4595,Urea cycle and associated pathways,M1,1,0
1,-2.5,GO:0006656,phosphatidylcholine biosynthetic process,M1,1,0
1,-2.5,R-HSA-75876,Synthesis of very long-chain fatty acyl-CoAs,M1,1,0
1,-2.7,GO:0001503,ossification,M1,1,0
1,-6.4,GO:0006575,cellular modified amino acid metabolic process,M1,1,0
1,-2.8,WP2880,Glucocorticoid receptor pathway,M1,1,0
1,-2.1,GO:0051931,regulation of sensory perception,M1,1,0
1,-2.8,M167,PID AP1 PATHWAY,M1,1,0
1,-4.1,R-HSA-5083635,Defective B3GALTL causes PpS,M1,1,0
1,-2.6,WP3612,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling,M1,1,0
1,-2.8,GO:0045137,development of primary sexual characteristics,M1,1,0
1,-2.6,GO:0098719,sodium ion import across plasma membrane,M1,1,0
1,-5.3,GO:0015849,organic acid transport,M1,1,0
1,-2.6,GO:0072311,glomerular epithelial cell differentiation,M1,1,0
1,-2.4,GO:0032508,DNA duplex unwinding,M1,1,0
1,-2.1,GO:0006766,vitamin metabolic process,M1,1,0
1,-5.9,GO:0002064,epithelial cell development,M1,1,0
1,-5.2,GO:0099183,"trans-synaptic signaling by BDNF, modulating synaptic transmission",M1,1,0
1,-3.8,GO:0006885,regulation of pH,M1,1,0
1,-2.9,R-HSA-2022377,Metabolism of Angiotensinogen to Angiotensins,M1,1,0
1,-2.3,GO:0001649,osteoblast differentiation,M1,1,0
1,-2.6,GO:0071295,cellular response to vitamin,M1,1,0
1,-5.3,GO:0050678,regulation of epithelial cell proliferation,M1,1,0
1,-2.7,WP497,Urea cycle and metabolism of amino groups,M1,1,0
1,-2.8,R-HSA-1474228,Degradation of the extracellular matrix,M1,1,0
1,-2.8,GO:0009117,nucleotide metabolic process,M1,1,0
1,-3.9,GO:0070372,regulation of ERK1 and ERK2 cascade,M1,1,0
1,-2.2,GO:0051642,centrosome localization,M1,1,0
1,-2.3,GO:0048660,regulation of smooth muscle cell proliferation,M1,1,0
1,-3.4,R-HSA-6785807,Interleukin-4 and Interleukin-13 signaling,M1,1,0
1,-4.8,GO:0003158,endothelium development,M1,1,0
1,-3.1,R-HSA-5668914,Diseases of metabolism,M1,1,0
1,-4,GO:0003018,vascular process in circulatory system,M1,1,0
1,-3.1,GO:0016114,terpenoid biosynthetic process,M1,1,0
1,-2.5,hsa00330,Arginine and proline metabolism,M1,1,0
1,-2.3,GO:0001763,morphogenesis of a branching structure,M1,1,0
1,-4.9,GO:0098739,import across plasma membrane,M1,1,0
1,-2.4,GO:0003156,regulation of animal organ formation,M1,1,0
1,-2.1,GO:0000724,double-strand break repair via homologous recombination,M1,1,0
1,-2.5,GO:0009065,glutamine family amino acid catabolic process,M1,1,0
1,-7.4,M3468,NABA ECM REGULATORS,M1,1,0
1,-2.1,GO:0009617,response to bacterium,M1,1,0
1,-3,GO:0072006,nephron development,M1,1,0
1,-2.3,GO:0002209,behavioral defense response,M1,1,0
1,-2.3,GO:0019217,regulation of fatty acid metabolic process,M1,1,0
1,-3.2,GO:0050891,multicellular organismal water homeostasis,M1,1,0
1,-4.8,WP5065,SARS-CoV-2 altering angiogenesis via NRP1,M1,1,0
1,-2.1,GO:0044242,cellular lipid catabolic process,M1,1,0
1,-3.1,R-HSA-381426,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),M1,1,0
1,-2.1,GO:0051896,regulation of protein kinase B signaling,M1,1,0
1,-4.6,GO:0007568,aging,M1,1,0
1,-2.4,GO:1901342,regulation of vasculature development,M1,1,0
1,-3.1,GO:0060341,regulation of cellular localization,M1,1,0
1,-2,GO:1905332,positive regulation of morphogenesis of an epithelium,M1,1,0
1,-3.4,GO:0006468,protein phosphorylation,M1,1,0
1,-2.7,GO:0001666,response to hypoxia,M1,1,0
1,-4.8,GO:0052547,regulation of peptidase activity,M1,1,0
1,-3.2,GO:0150104,transport across blood-brain barrier,M1,1,0
1,-2.7,GO:0099515,actin filament-based transport,M1,1,0
1,-2.5,GO:0038084,vascular endothelial growth factor signaling pathway,M1,1,0
1,-3,GO:0006749,glutathione metabolic process,M1,1,0
1,-2.3,GO:0032989,cellular component morphogenesis,M1,1,0
1,-3.7,GO:0006560,proline metabolic process,M1,1,0
1,-2.1,GO:1904029,regulation of cyclin-dependent protein kinase activity,M1,1,0
1,-2.7,GO:0032496,response to lipopolysaccharide,M1,1,0
1,-3.3,GO:0015801,aromatic amino acid transport,M1,1,0
1,-4.6,GO:0010575,positive regulation of vascular endothelial growth factor production,M1,1,0
1,-2.1,M255,PID HIF1 TFPATHWAY,M1,1,0
1,-2.9,M18,PID INTEGRIN1 PATHWAY,M1,1,0
1,-2.4,GO:0051894,positive regulation of focal adhesion assembly,M1,1,0
1,-2.1,GO:0030595,leukocyte chemotaxis,M1,1,0
1,-2.3,GO:0008299,isoprenoid biosynthetic process,M1,1,0
1,-2.2,GO:0006639,acylglycerol metabolic process,M1,1,0
1,-3.4,GO:0006563,L-serine metabolic process,M1,1,0
1,-4.3,GO:0048875,chemical homeostasis within a tissue,M1,1,0
1,-3.7,GO:0048589,developmental growth,M1,1,0
1,-2.5,GO:0140013,meiotic nuclear division,M1,1,0
1,-6.2,GO:0001822,kidney development,M1,1,0
1,-2.4,GO:0120035,regulation of plasma membrane bounded cell projection organization,M1,1,0
1,-3.6,hsa04974,Protein digestion and absorption,M1,1,0
1,-2.7,GO:0009259,ribonucleotide metabolic process,M1,1,0
1,-2.3,GO:0030178,negative regulation of Wnt signaling pathway,M1,1,0
1,-3.8,GO:0022408,negative regulation of cell-cell adhesion,M1,1,0
1,-2.5,GO:0006865,amino acid transport,M1,1,0
1,-6.7,R-HSA-109582,Hemostasis,M1,1,0
1,-6.2,GO:0006650,glycerophospholipid metabolic process,M1,1,0
1,-2.1,GO:0046467,membrane lipid biosynthetic process,M1,1,0
1,-3.8,GO:0006066,alcohol metabolic process,M1,1,0
1,-3.1,GO:1901888,regulation of cell junction assembly,M1,1,0
1,-2.5,GO:0006658,phosphatidylserine metabolic process,M1,1,0
1,-2.3,GO:0050817,coagulation,M1,1,0
1,-2.5,GO:0045765,regulation of angiogenesis,M1,1,0
1,-2.3,GO:0034754,cellular hormone metabolic process,M1,1,0
1,-2.2,R-HSA-211859,Biological oxidations,M1,1,0
1,-3.6,GO:0001819,positive regulation of cytokine production,M1,1,0
1,-3.1,GO:0032233,positive regulation of actin filament bundle assembly,M1,1,0
1,-2.9,GO:0030104,water homeostasis,M1,1,0
1,-5.9,GO:1901615,organic hydroxy compound metabolic process,M1,1,0
1,-3.1,WP306,Focal adhesion,M1,1,0
1,-2.1,GO:0045598,regulation of fat cell differentiation,M1,1,0
1,-2.9,GO:0030903,notochord development,M1,1,0
1,-2.3,GO:0090132,epithelium migration,M1,1,0
1,-2.1,GO:0072078,nephron tubule morphogenesis,M1,1,0
1,-8.6,GO:0008610,lipid biosynthetic process,M1,1,0
1,-3.3,GO:0006163,purine nucleotide metabolic process,M1,1,0
1,-3.2,GO:1905114,cell surface receptor signaling pathway involved in cell-cell signaling,M1,1,0
1,-2.5,WP2865,IL1 and megakaryocytes in obesity,M1,1,0
1,-4.8,GO:0006633,fatty acid biosynthetic process,M1,1,0
1,-2.1,GO:0001501,skeletal system development,M1,1,0
1,-2.3,GO:0006261,DNA-dependent DNA replication,M1,1,0
1,-2.2,GO:0002244,hematopoietic progenitor cell differentiation,M1,1,0
1,-3.4,GO:2000179,positive regulation of neural precursor cell proliferation,M1,1,0
1,-2.4,GO:0001662,behavioral fear response,M1,1,0
1,-2.7,GO:0045056,transcytosis,M1,1,0
1,-2.3,R-HSA-2980736,Peptide hormone metabolism,M1,1,0
1,-3.9,GO:0098660,inorganic ion transmembrane transport,M1,1,0
1,-3.6,M239,PID A6B1 A6B4 INTEGRIN PATHWAY,M1,1,0
1,-2.1,GO:0010594,regulation of endothelial cell migration,M1,1,0
1,-4,R-HSA-5173214,O-glycosylation of TSR domain-containing proteins,M1,1,0
1,-4.7,R-HSA-983712,Ion channel transport,M1,1,0
1,-3.9,hsa00260,"Glycine, serine and threonine metabolism",M1,1,0
1,-2.3,GO:0051591,response to cAMP,M1,1,0
1,-2.4,GO:0008207,C21-steroid hormone metabolic process,M1,1,0
1,-3.6,GO:0006970,response to osmotic stress,M1,1,0
1,-2.4,GO:0042278,purine nucleoside metabolic process,M1,1,0
1,-5.2,GO:0099191,trans-synaptic signaling by BDNF,M1,1,0
1,-5,GO:0002009,morphogenesis of an epithelium,M1,1,0
1,-3.3,GO:0007548,sex differentiation,M1,1,0
1,-3.6,GO:0030003,cellular cation homeostasis,M1,1,0
1,-2.3,GO:0048639,positive regulation of developmental growth,M1,1,0
1,-2.2,GO:0150117,positive regulation of cell-substrate junction organization,M1,1,0
1,-2.3,GO:0090303,positive regulation of wound healing,M1,1,0
1,-2.3,GO:0072175,epithelial tube formation,M1,1,0
1,-2.2,GO:0000079,regulation of cyclin-dependent protein serine/threonine kinase activity,M1,1,0
1,-2,GO:0010517,regulation of phospholipase activity,M1,1,0
1,-2.5,GO:1901292,nucleoside phosphate catabolic process,M1,1,0
1,-2.1,GO:0035296,regulation of tube diameter,M1,1,0
1,-2.9,GO:0071634,regulation of transforming growth factor beta production,M1,1,0
1,-2.6,GO:0035162,embryonic hemopoiesis,M1,1,0
1,-3.4,GO:0055082,cellular chemical homeostasis,M1,1,0
1,-2.5,GO:0001523,retinoid metabolic process,M1,1,0
1,-6.1,hsa05200,Pathways in cancer,M1,1,0
1,-5.2,GO:0098771,inorganic ion homeostasis,M1,1,0
1,-2.2,GO:0030837,negative regulation of actin filament polymerization,M1,1,0
1,-4.4,GO:0071470,cellular response to osmotic stress,M1,1,0
1,-2.2,GO:0030865,cortical cytoskeleton organization,M1,1,0
1,-2.4,GO:1902904,negative regulation of supramolecular fiber organization,M1,1,0
1,-3,GO:0048565,digestive tract development,M1,1,0
1,-2.2,GO:0045667,regulation of osteoblast differentiation,M1,1,0
1,-9,GO:0030855,epithelial cell differentiation,M1,1,0
1,-3,GO:0070542,response to fatty acid,M1,1,0
1,-2.9,GO:1901992,positive regulation of mitotic cell cycle phase transition,M1,1,0
1,-3.8,GO:0048871,multicellular organismal homeostasis,M1,1,0
1,-3.3,GO:0008360,regulation of cell shape,M1,1,0
1,-2.9,GO:0007162,negative regulation of cell adhesion,M1,1,0
1,-2.9,GO:0009150,purine ribonucleotide metabolic process,M1,1,0
1,-2.8,GO:0070482,response to oxygen levels,M1,1,0
1,-8.3,R-HSA-75205,Dissolution of Fibrin Clot,M1,1,0
1,-11,R-HSA-382551,Transport of small molecules,M1,1,0
1,-3.2,GO:0001654,eye development,M1,1,0
1,-3,GO:0009116,nucleoside metabolic process,M1,1,0
1,-2.7,GO:0032272,negative regulation of protein polymerization,M1,1,0
1,-2.6,M211,PID HEDGEHOG 2PATHWAY,M1,1,0
1,-3.8,GO:0042445,hormone metabolic process,M1,1,0
1,-3,GO:0014020,primary neural tube formation,M1,1,0
1,-2.5,hsa04510,Focal adhesion,M1,1,0
1,-3.6,GO:0051493,regulation of cytoskeleton organization,M1,1,0
1,-3.5,WP2873,Aryl hydrocarbon receptor pathway,M1,1,0
1,-3.1,GO:0030900,forebrain development,M1,1,0
1,-3,GO:0050679,positive regulation of epithelial cell proliferation,M1,1,0
1,-3.3,GO:0045661,regulation of myoblast differentiation,M1,1,0
1,-2.7,GO:0048286,lung alveolus development,M1,1,0
1,-3.6,GO:1902903,regulation of supramolecular fiber organization,M1,1,0
1,-2.6,hsa04614,Renin-angiotensin system,M1,1,0
1,-4.7,GO:0001701,in utero embryonic development,M1,1,0
1,-3.1,GO:0060914,heart formation,M1,1,0
1,-3.8,GO:0008064,regulation of actin polymerization or depolymerization,M1,1,0
1,-5.6,WP2882,Nuclear receptors meta-pathway,M1,1,0
1,-4.5,R-HSA-114608,Platelet degranulation,M1,1,0
1,-3.9,GO:0035725,sodium ion transmembrane transport,M1,1,0
1,-2.6,GO:0009314,response to radiation,M1,1,0
1,-2.3,GO:0010565,regulation of cellular ketone metabolic process,M1,1,0
1,-7.2,R-HSA-1483257,Phospholipid metabolism,M1,1,0
1,-3.4,GO:0003128,heart field specification,M1,1,0
1,-2.3,GO:0010564,regulation of cell cycle process,M1,1,0
1,-2.7,R-HSA-9006934,Signaling by Receptor Tyrosine Kinases,M1,1,0
1,-4.2,GO:0001936,regulation of endothelial cell proliferation,M1,1,0
1,-2.9,GO:0016055,Wnt signaling pathway,M1,1,0
1,-3.9,GO:0048732,gland development,M1,1,0
1,-2.6,GO:0050900,leukocyte migration,M1,1,0
1,-2.3,GO:0045931,positive regulation of mitotic cell cycle,M1,1,0
1,-4.3,GO:0071396,cellular response to lipid,M1,1,0
1,-3.1,GO:0010574,regulation of vascular endothelial growth factor production,M1,1,0
1,-2.6,GO:0046128,purine ribonucleoside metabolic process,M1,1,0
1,-6.8,GO:0001944,vasculature development,M1,1,0
1,-4.9,R-HSA-8978868,Fatty acid metabolism,M1,1,0
1,-2.6,GO:0070373,negative regulation of ERK1 and ERK2 cascade,M1,1,0
1,-2.8,R-HSA-449147,Signaling by Interleukins,M1,1,0
1,-4.1,hsa04610,Complement and coagulation cascades,M1,1,0
1,-2.6,WP5055,Burn wound healing,M1,1,0
1,-2.4,GO:0061138,morphogenesis of a branching epithelium,M1,1,0
1,-2.3,GO:0051099,positive regulation of binding,M1,1,0
1,-6.1,GO:0006820,anion transport,M1,1,0
1,-3.8,R-HSA-977347,Serine biosynthesis,M1,1,0
1,-2.3,GO:0048762,mesenchymal cell differentiation,M1,1,0
1,-2.6,GO:0045723,positive regulation of fatty acid biosynthetic process,M1,1,0
1,-4.2,GO:0120254,olefinic compound metabolic process,M1,1,0
1,-2.6,GO:0030097,hemopoiesis,M1,1,0
1,-2.8,GO:0046395,carboxylic acid catabolic process,M1,1,0
1,-2.6,hsa04514,Cell adhesion molecules,M1,1,0
1,-7.2,WP4754,IL-18 signaling pathway,M1,1,0
1,-4.8,GO:0016485,protein processing,M1,1,0
1,-3.3,GO:0030497,fatty acid elongation,M1,1,0
1,-2.2,R-HSA-9013406,RHOQ GTPase cycle,M1,1,0
1,-2.4,GO:0098661,inorganic anion transmembrane transport,M1,1,0
1,-3.7,GO:0048844,artery morphogenesis,M1,1,0
1,-5.1,M5884,NABA CORE MATRISOME,M1,1,0
1,-3.6,GO:0003096,renal sodium ion transport,M1,1,0
1,-2.6,GO:0009651,response to salt stress,M1,1,0
1,-3,GO:0090068,positive regulation of cell cycle process,M1,1,0
1,-2.7,GO:0002520,immune system development,M1,1,0
1,-4.8,GO:0030195,negative regulation of blood coagulation,M1,1,0
1,-3.7,GO:2000048,negative regulation of cell-cell adhesion mediated by cadherin,M1,1,0
1,-2.9,GO:0032956,regulation of actin cytoskeleton organization,M1,1,0
1,-3.8,GO:0031347,regulation of defense response,M1,1,0
1,-2.9,GO:0072009,nephron epithelium development,M1,1,0
1,-2.4,GO:0035640,exploration behavior,M1,1,0
1,-2.2,M72,PID NECTIN PATHWAY,M1,1,0
1,-4.4,GO:0061028,establishment of endothelial barrier,M1,1,0
1,-3.3,GO:0042761,very long-chain fatty acid biosynthetic process,M1,1,0
1,-2.4,GO:0051347,positive regulation of transferase activity,M1,1,0
1,-2.8,GO:0033555,multicellular organismal response to stress,M1,1,0
1,-4,R-HSA-194313,VEGF ligand-receptor interactions,M1,1,0
1,-3.8,GO:0090270,regulation of fibroblast growth factor production,M1,1,0
1,-4.6,GO:0060562,epithelial tube morphogenesis,M1,1,0
1,-2.9,GO:0060840,artery development,M1,1,0
1,-3.8,GO:0016102,diterpenoid biosynthetic process,M1,1,0
1,-4,GO:0060828,regulation of canonical Wnt signaling pathway,M1,1,0
1,-5,hsa00561,Glycerolipid metabolism,M1,1,0
1,-3.6,GO:0061045,negative regulation of wound healing,M1,1,0
1,-2.6,GO:0001894,tissue homeostasis,M1,1,0
1,-4,GO:2000826,regulation of heart morphogenesis,M1,1,0
1,-2.3,GO:0032392,DNA geometric change,M1,1,0
1,-2.2,GO:0048010,vascular endothelial growth factor receptor signaling pathway,M1,1,0
1,-5.2,GO:1903034,regulation of response to wounding,M1,1,0
1,-4.8,GO:0030193,regulation of blood coagulation,M1,1,0
1,-2.1,R-HSA-1592389,Activation of Matrix Metalloproteinases,M1,1,0
1,-2.5,hsa05130,Pathogenic Escherichia coli infection,M1,1,0
1,-3.1,WP558,Complement and coagulation cascades,M1,1,0
1,-2.1,GO:0006875,cellular metal ion homeostasis,M1,1,0
1,-4.7,GO:1900046,regulation of hemostasis,M1,1,0
1,-3.5,GO:0045446,endothelial cell differentiation,M1,1,0
1,-4.8,GO:0098655,cation transmembrane transport,M1,1,0
1,-3,hsa05323,Rheumatoid arthritis,M1,1,0
1,-2.3,R-HSA-1855204,Synthesis of IP3 and IP4 in the cytosol,M1,1,0
1,-7.2,GO:0048514,blood vessel morphogenesis,M1,1,0
1,-2.1,R-HSA-6811434,COPI-dependent Golgi-to-ER retrograde traffic,M1,1,0
1,-2.5,GO:0072010,glomerular epithelium development,M1,1,0
1,-2.1,GO:0030858,positive regulation of epithelial cell differentiation,M1,1,0
1,-2.6,GO:0001938,positive regulation of endothelial cell proliferation,M1,1,0
1,-2.3,hsa05206,MicroRNAs in cancer,M1,1,0
1,-3.6,GO:0003014,renal system process,M1,1,0
1,-2.5,hsa00565,Ether lipid metabolism,M1,1,0
1,-2.1,GO:0010639,negative regulation of organelle organization,M1,1,0
1,-2.4,GO:0051056,regulation of small GTPase mediated signal transduction,M1,1,0
1,-3.6,GO:0003139,secondary heart field specification,M1,1,0
1,-3,GO:0032970,regulation of actin filament-based process,M1,1,0
1,-5.3,GO:0061041,regulation of wound healing,M1,1,0
1,-3.4,R-HSA-3781865,Diseases of glycosylation,M1,1,0
1,-4,GO:0061042,vascular wound healing,M1,1,0
1,-2.5,GO:0002237,response to molecule of bacterial origin,M1,1,0
1,-3.4,GO:0010038,response to metal ion,M1,1,0
1,-4.3,GO:0008654,phospholipid biosynthetic process,M1,1,0
1,-3.3,GO:0008643,carbohydrate transport,M1,1,0
1,-2.7,GO:1904018,positive regulation of vasculature development,M1,1,0
1,-2.2,GO:0006721,terpenoid metabolic process,M1,1,0
1,-2.7,GO:0051592,response to calcium ion,M1,1,0
1,-2.9,GO:0015698,inorganic anion transport,M1,1,0
1,-2,GO:0042130,negative regulation of T cell proliferation,M1,1,0
1,-3.1,GO:0046683,response to organophosphorus,M1,1,0
1,-2.6,GO:0007051,spindle organization,M1,1,0
1,-3.7,GO:0046474,glycerophospholipid biosynthetic process,M1,1,0
1,-2,R-HSA-8980692,RHOA GTPase cycle,M1,1,0
1,-3.6,M183,PID IL6 7 PATHWAY,M1,1,0
1,-8.5,GO:0035239,tube morphogenesis,M1,1,0
1,-2.3,GO:0032835,glomerulus development,M1,1,0
1,-2.4,GO:0010631,epithelial cell migration,M1,1,0
1,-4.7,GO:1900047,negative regulation of hemostasis,M1,1,0
1,-3.1,GO:0035641,locomotory exploration behavior,M1,1,0
1,-4.5,GO:1901605,alpha-amino acid metabolic process,M1,1,0
1,-3.5,GO:0030833,regulation of actin filament polymerization,M1,1,0
1,-3.2,GO:0006520,cellular amino acid metabolic process,M1,1,0
1,-2.8,GO:0030050,vesicle transport along actin filament,M1,1,0
1,-2.8,GO:0001841,neural tube formation,M1,1,0
1,-2.6,GO:0048638,regulation of developmental growth,M1,1,0
1,-2.4,GO:0042886,amide transport,M1,1,0
1,-3.4,GO:0007584,response to nutrient,M1,1,0
1,-2.7,GO:0008652,cellular amino acid biosynthetic process,M1,1,0
1,-6.1,GO:0072001,renal system development,M1,1,0
1,-3.6,GO:0098662,inorganic cation transmembrane transport,M1,1,0
1,-2.3,GO:0031344,regulation of cell projection organization,M1,1,0
1,-2.4,GO:0006637,acyl-CoA metabolic process,M1,1,0
1,-3,GO:0060055,angiogenesis involved in wound healing,M1,1,0
1,-2.7,GO:0050729,positive regulation of inflammatory response,M1,1,0
1,-2.2,GO:0007599,hemostasis,M1,1,0
1,-4.3,GO:0030162,regulation of proteolysis,M1,1,0
1,-2.6,GO:0048534,hematopoietic or lymphoid organ development,M1,1,0
1,-2,GO:0061333,renal tubule morphogenesis,M1,1,0
1,-4.9,GO:0098657,import into cell,M1,1,0
1,-4.5,R-HSA-15869,Metabolism of nucleotides,M1,1,0
1,-2.2,M83,PID CDC42 REG PATHWAY,M1,1,0
1,-2.1,GO:0090050,positive regulation of cell migration involved in sprouting angiogenesis,M1,1,0
1,-2.5,GO:0030856,regulation of epithelial cell differentiation,M1,1,0
1,-2.9,GO:0008015,blood circulation,M1,1,0
1,-2.3,hsa00480,Glutathione metabolism,M1,1,0
1,-3.2,GO:0045604,regulation of epidermal cell differentiation,M1,1,0
1,-2.1,GO:0006821,chloride transport,M1,1,0
1,-2.5,GO:0042572,retinol metabolic process,M1,1,0
1,-2.1,R-HSA-9614085,FOXO-mediated transcription,M1,1,0
1,-2.9,GO:0045682,regulation of epidermis development,M1,1,0
1,-2.2,GO:0048661,positive regulation of smooth muscle cell proliferation,M1,1,0
1,-5.2,GO:1990748,cellular detoxification,M1,1,0
1,-2.6,GO:0009123,nucleoside monophosphate metabolic process,M1,1,0
1,-2.9,GO:1902808,positive regulation of cell cycle G1/S phase transition,M1,1,0
1,-7.3,GO:0032787,monocarboxylic acid metabolic process,M1,1,0
1,-2.2,GO:0110110,positive regulation of animal organ morphogenesis,M1,1,0
1,-4.6,GO:0043129,surfactant homeostasis,M1,1,0
1,-3.7,GO:0016042,lipid catabolic process,M1,1,0
1,-5.2,GO:0052548,regulation of endopeptidase activity,M1,1,0
1,-2.5,GO:0007423,sensory organ development,M1,1,0
1,-3.4,GO:0051272,positive regulation of cellular component movement,M1,1,0
1,-2.3,GO:0090287,regulation of cellular response to growth factor stimulus,M1,1,0
1,-3,GO:0048569,post-embryonic animal organ development,M1,1,0
1,-2,GO:2000377,regulation of reactive oxygen species metabolic process,M1,1,0
1,-4,GO:0045017,glycerolipid biosynthetic process,M1,1,0
1,-4.2,GO:0030323,respiratory tube development,M1,1,0
1,-7.9,R-HSA-425407,SLC-mediated transmembrane transport,M1,1,0
1,-6.9,GO:0006631,fatty acid metabolic process,M1,1,0
1,-5.6,GO:0048568,embryonic organ development,M1,1,0
1,-2.6,WP2586,Aryl hydrocarbon receptor Netpath,M1,1,0
